Healthcare | 02 March 2026
Zenex Animal Health makes strategic European play with VievePharm acquisition
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
Semaglutide—a glucagon?like peptide?1 receptor agonist (GLP-1RA) sold as Ozempic and Rybelsus for type 2 diabetes, and Wegovy for weight management and cardiovascular risk reduction
The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
The proceeds from the QIP will be used primarily to accelerate the nationwide expansion of the COCO stores of Davaindia nationwide
The opening of our 1000th pharmacy in Karnataka marks an important step
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
Captured microbes are then neutralized on engineered microbicidal surfaces
The launch of the study was on the occasion of the International Day of Persons with Disabilities
_Logo.png){kind=logo}
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
Under the proposed terms, Vaximm would secure a $20 million upfront payment, up to $815 million tied to clinical, regulatory, and commercial milestones
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
.jpg)
Subscribe To Our Newsletter & Stay Updated
